# Cyclo Therapeutics, Inc.

Cyclo Therapeutics, Inc. is a company headquartered in Gainesville, FL, United States.

## Company overview

- **Legal name:** Cyclo Therapeutics, Inc.
- **Former names in filing history:** CTD HOLDINGS INC (2000-11-30 to 2019-09-30); CYCLODEXTRIN TECHNOLOGIES DEVELOPMENT INC (1996-08-14 to 2000-03-30)
- **Classification:** Company
- **Industry (SIC):** 2836 — Biological Products, (No Diagnostic Substances)
- **Headquarters:** Gainesville, FL, United States
- **Incorporated in:** NV
- **Fiscal year end:** December 31
- **SEC CIK:** 0000922247

## About

Cyclo Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000922247, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2024-03-18, it reported annual revenue of USD 1,076,405; net income of USD -20,057,302; total assets of USD 13,247,538 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2023 (period ended 2023-12-31)

- **Revenue:** $1.1M (USD 1,076,405)
- **Net income:** -$20.1M (USD -20,057,302)
- **Total assets:** $13.2M (USD 13,247,538)
- **Cash and equivalents:** $9.2M (USD 9,246,592)
- **Operating cash flow:** -$16.2M (USD -16,185,026)

### FY2022 (period ended 2022-12-31)

- **Revenue:** $1.4M (USD 1,375,760)
- **Net income:** -$15.5M (USD -15,450,888)
- **Total assets:** $4.2M (USD 4,215,213)
- **Cash and equivalents:** $1.5M (USD 1,543,418)
- **Operating cash flow:** -$15.1M (USD -15,114,241)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $1.6M (USD 1,585,756)
- **Net income:** -$14.3M (USD -14,286,655)
- **Total assets:** $19.5M (USD 19,520,833)
- **Cash and equivalents:** $16.6M (USD 16,612,711)
- **Operating cash flow:** -$15.0M (USD -15,005,298)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $903,376 (USD 903,376)
- **Net income:** -$8.9M (USD -8,941,603)
- **Total assets:** $14.2M (USD 14,187,964)
- **Cash and equivalents:** $12.8M (USD 12,846,113)
- **Operating cash flow:** -$8.5M (USD -8,540,185)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2025-03-26 — period 2025-03-25 — FORM 8-K
- Form 8-K — filed 2025-03-24 — period 2025-03-20 — FORM 8-K
- Form 8-K — filed 2025-03-06 — period 2025-03-06 — FORM 8-K
- Form 8-K — filed 2025-02-04 — period 2025-02-04 — FORM 8-K
- Form 8-K — filed 2025-01-13 — period 2025-01-10 — FORM 8-K
- Form 8-K — filed 2025-01-03 — period 2025-01-03 — FORM 8-K
- Form 8-K — filed 2024-12-23 — period 2024-12-18 — FORM 8-K
- Form 10-K/A — filed 2024-12-18 — period 2023-12-31 — FORM 10-K/A
- Form 8-K — filed 2024-12-05 — period 2024-12-05 — FORM 8-K
- Form 10-K/A — filed 2024-11-26 — period 2023-12-31 — FORM 10-K/A
- Form 10-Q — filed 2024-11-14 — period 2024-09-30 — FORM 10-Q
- Form 8-K — filed 2024-11-08 — period 2024-11-07 — FORM 8-K

---

Updated: 2026-10-23T20:08:00Z

Canonical page: https://altss.com/profile/cyclo-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology